載入...
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder
BACKGROUND: Major depressive disorder (MDD) is a serious illness in children and adolescents. Vilazodone is a selective serotonin reuptake inhibitor approved for MDD in adults. This study evaluated the efficacy, safety, and tolerability of vilazodone in adolescent patients, ages 12–17 years, with MD...
Na minha lista:
| 發表在: | Paediatr Drugs |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer International Publishing
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6028869/ https://ncbi.nlm.nih.gov/pubmed/29633166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40272-018-0290-4 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|